Healthcare users’ satisfaction with the doctor’s care
| Involvement level | Mean (95% CI)* n=6755 | Decision (group) | Mean (95% CI) n=6755 | Subgroup (course) | Mean (95% CI) n=6755 |
| No involvement | 3.81 (3.77 to 3.86) P<0.001 | No PSA1 | 3.87 (3.81 to 3.93) | A (no PCa) | 4.09 (4.01 to 4.18) |
| B (treatable PCa) | 3.87 (3.76 to 3.98) | ||||
| C (non-treatable PCa) | 3.61 (3.50 to 3.71) | ||||
| PSA2 | 3.77 (3.70 to 3.83) | A (no PCa) | 4.03 (3.93 to 4.12) | ||
| B (treatable PCa) | 3.71 (3.61 to 3.82) | ||||
| C (non-treatable PCa) | 3.50 (3.37 to 3.62) | ||||
| Nudging against PSA | 3.68 (3.63 to 3.73) P<0.001 | No PSA3 | 3.60 (3.53 to 3.68) | A (no PCa) | 3.98 (3.89 to 4.07) |
| B (treatable PCa) | 3.52 (3.39 to 3.64) | ||||
| C (non-treatable PCa) | 3.33 (3.20 to 3.45) | ||||
| PSA4 | 3.76 (3.69 to 3.83) | A (no PCa) | 4.09 (4.00 to 4.18) | ||
| B (treatable PCa) | 3.70 (3.58 to 3.83) | ||||
| C (non-treatable PCa) | 3.46 (3.33 to 3.58) | ||||
| Neutral info (Reference) | 4.00 (3.95 to 4.04) | No PSA5 | 3.96 (3.90 to 4.02) | A (no PCa) | 4.15 (4.05 to 4.24) |
| B (treatable PCa) | 4.04 (3.95 to 4.13) | ||||
| C (non-treatable PCa) | 3.67 (3.54 to 3.79) | ||||
| PSA6 | 4.03 (3.97 to 4.09) | A (no PCa) | 4.26 (4.18 to 4.35) | ||
| B (treatable PCa) | 4.01 (3.92 to 4.11) | ||||
| C (non-treatable PCa) | 3.81 (3.70 to 3.92) | ||||
| Nudging for PSA | 4.05 (4.02 to 4.09) P=0.040 | No PSA7 | 4.07 (4.02 to 4.13) | A (no PCa) | 4.25 (4.17 to 4.34) |
| B (treatable PCa) | 4.16 (4.07 to 4.25) | ||||
| C (non-treatable PCa) | 3.80 (3.70 to 3.90) | ||||
| PSA8 | 4.03 (3.98 to 4.09) | A (no PCa) | 4.19 (4.10 to 4.28) | ||
| B (treatable PCa) | 4.04 (3.95 to 4.13) | ||||
| C (non treatable PCa) | 3.89 (3.79 to 3.98) | ||||
| SDM | 4.07 (4.03 to 4.11) P=0.008 | No PSA9 | 4.08 (4.03 to 4.13) | A (no PCa) | 4.19 (4.10 to 4.27) |
| B (treatable PCa) | 4.11 (4.03 to 4.20) | ||||
| C (non treatable PCa) | 3.91 (3.82 to 4.01) | ||||
| PSA10 | 4.06 (4.00 to 4.12) | A (no PCa) | 4.19 (4.08 to 4.29) | ||
| B (treatable PCa) | 4.10 (4.01 to 4.20) | ||||
| C (non treatable PCa) | 3.89 (3.79 to 4.00) |
*‘1’ means very dissatisfied and ‘5’ very satisfied.
PCa, prostate cancer; PSA, prostate-specific antigen; SDM, shared decision-making.